Objective
Specific Objectives:
The basic work concentrating on the development of analytical methods and procedures will be problem oriented and is essential to generate the basis for a strong analytical capability. They will be applied for the characterisation of clinical reference materials in co-operation with the RM Unit of IRMM and to comply with the needs of the European certified reference system. The main objectives for 2003 are therefore:
1. To characterise the purity of HbA1c and HbA0 hemoglobin isoforms and to implement the IFCC reference method for glycated hemoglobin for the certification of matrix based reference materials. Deliverables: set of data for certification; scientific publication;
2. To develop a candidate reference method for myoglobin based on LC- MS. Deliverables: progress in method development; scientific publication;
3. To determine the purity of crystalline thyroxine and triiodoniumthyronin (thyroid hormones). Deliverables: set of data to be used within certification;
4. To develop a method for the characterisation and purity check of enriched or isolated TSH (thyroid stimulating hormone) isoforms using LC-MS;
5. To perform exploratory research in fields of interest in relation to clinical chemistry (eg. proteins characterisation and determination using CE-MS and LC- MS) The recently established Joint Committee for Traceability in Laboratory Medicine brings together the most important players not only in Europe, but globally. It is the reference network for clinical measurements and therefore fully complies with the ERA objectives. Furthermore this action could contribute to the creation of specialised expert networks with laboratories of the Member and Candidate Countries. The COST project already involves two partners from the Czech Republic. Training for young scientists at post- doctoral level is another important aspect. Anticipated milestones and schedule.
Planned Deliverables:
Set of data for certification; scientific publication on the purity of HbA1c and HbA0 hemoglobin isoforms progress in method development of a candidate reference method for myoglobin based on LC-MS; scientific publication set of data to be used within certification of crystalline thyroxine and triiodoniumthyronin (thyroid hormones).
Summary of the Action:
As the IVD Directive (98/79/EC) requires traceability of clinical data to reference materials or measurements of higher metrological order, quality requirements are necessary for the new CRMs to be developed in the Action Reference systems for in vitro diagnostics and health of this ISA. The major emphasis in this action will thus be on the development and validation of advanced characterisation methods for such protein markers and their application to establish reference values for CRM and PT materials. This will include the optimisation of separation techniques based on Liquid Chromatography, 2D Gel Electrophoresis and Capillary Electrophoresis for characterisation of impurities of the proteins, the development of elaborate mass spectrometric methods based on MS-MS, MALDI-TOF for the determination of the molecular weight of the proteins and their purity, and finally the establishment of methods for the assessment of the quantity of a specific protein in clinical matrix like serum or urine.
While the major emphasis of this action will be on protein diagnostic markers, analytical support will also be provided for other classes of substances, such as hormones and other organic and inorganic compounds. Rationale This action will contribute to improve the EU diagnostic system and thereby directly supports the implementation of the "In-vitro diagnostics and medical devices" (98/79/EC) IVD Directive. This action will provide the necessary analytical support for the development and value assignment of Certified Reference Materials and Proficiency Testing Materials used in BIPM and EUROMET pilot studies or Key Comparisons. The research activities will mainly focus on the development of analytical methods for protein markers. This task is extraordinary challenging since proteins presently used for clinical diagnosis are often heterogeneous (thus the strong dependence of clinical laboratory results on the calibrants used and different results obtained in different laboratories) requiring clear understanding of the isoform distributions and activity in order to set up efficient standardisation.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences chemical sciences analytical chemistry
- natural sciences chemical sciences inorganic chemistry inorganic compounds
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences chemical sciences electrochemistry electrophoresis
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
B-2440 Geel
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.